• Welcome to ScanBalt Business

    ScanBalt Business is a business support and service for ScanBalt BioRegion delivered by ScanBalt® fmba. It gives easy access to leading companies and clusters within health and life sciences in the Nordic and Baltic countries, Northern Germany, Northern Netherlands and Northwestern Russia – The Top of Europe.
  • Today's Portrait Highlights


    PRO SCIENCE Poland Ltd

    Pro Science Poland is an innovative company created on the basis on the experience and knowledge of its employees. Pro Science interacts with the academic community in order to facilitate the transfer of the academic knowledge and experience into an innovative economical sectors. The company provides support for technology transfer, intellectual property counseling and investments assessment as well as application processes for project financing. Substantially important part of our company's activity is organization of training, workshops and conferences. The company also provides service in the following fields: professional translations, market research, public relations and marketing.


    Visit Website

    QPS

    Founded in 1995, QPS is a GLP/GCP-compliant contract research organization (CRO) supporting discovery, preclinical and clinical drug development. We provide quality services to pharmaceutical and biotechnology clients Worldwide. QPS is well known as a leading CRO for CNS drug development. The availability of the most predictive disease models and unparalleled experience with studies performed for biopharmaceutical companies of all sizes turn QPS into the first choice for most research needs. Validated transgenic and non-transgenic in vitro and in vivo models cover most targets of AD, PD, HD and other neurodegenerative diseases.


    Visit Website

    QPS

    Founded in 1995, QPS is a GLP/GCP-compliant contract research organization (CRO) supporting discovery, preclinical and clinical drug development. We provide quality services to pharmaceutical and biotechnology clients Worldwide. QPS is well known as a leading CRO for CNS drug development. The availability of the most predictive disease models and unparalleled experience with studies performed for biopharmaceutical companies of all sizes turn QPS into the first choice for most research needs. Validated transgenic and non-transgenic in vitro and in vivo models cover most targets of AD, PD, HD and other neurodegenerative diseases.


    Visit Website
  • Add your advertisement
    free of charge on
    www.scanbaltbusiness.com Read more
  • linkedin-logo
    Learn about ScanBalt®
    www.scanbalt.org
    Visit
  • Subscribe to ScanBalt Business Club Information

  • country-158013_640

    country-158013_640